Work

The Biology and Clinical Development of MEK Inhibitors for Cancer

Year: 2014

Type: article

Source: Drugs

DOI: 10.1007/s40265-014-0315-4

Authors: Jason J. Luke, Patrick A. Ott, Geoffrey I. Shapiro

Institutions: University of Chicago, University of Chicago Medicine Comprehensive Cancer Center, Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2013658947

FWCI: 1.338

Cites: 121

Cited by: 43

Related to: 10